☆ 4.6 Article

A case of multiple thrombosis and septic shock in a critically ill patient with Omicron infection

JOURNAL OF INFECTION AND PUBLIC HEALTH (2022)

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Lihong Liu et al.

Summary: The B.1.1.529/Omicron variant of SARS-CoV-2, initially detected in southern Africa, has rapidly spread globally and is expected to become dominant due to its enhanced transmissibility in the coming weeks. This variant poses a threat to the efficacy of current COVID-19 vaccines and antibody therapies due to its significant antibody resistance. Even individuals who have received vaccines and booster doses may have reduced neutralizing activity against B.1.1.529.

NATURE (2022)

Add to Collection
Article Medicine, General & Internal

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Charlotte A. Bradbury et al.

Summary: The study results showed that among critically ill patients with COVID-19, treatment with an antiplatelet agent compared with no antiplatelet agent did not significantly improve the number of organ support-free days within 21 days. The use of antiplatelet therapy in critically ill patients with COVID-19 did not show significant benefits.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection
Article Medicine, Research & Experimental

The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule

Xuhui Shen et al.

Summary: Lianhua-Qingwen capsule is a widely used traditional Chinese medicine for treating various respiratory diseases, such as SARS and COVID-19. Its main active ingredients can target specific molecules and have therapeutic effects.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation

Joshua K. Salabei et al.

Summary: COVID-19-associated coagulopathy, potentially caused by various etiologies, highlights the importance of endothelial dysfunction. Monitoring elevated D-dimers and prolonged prothrombin times can guide anticoagulation therapy. Prophylactic anticoagulation is crucial in hospitalized COVID-19 patients.

HEART & LUNG (2021)

Add to Collection
Review Critical Care Medicine

Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019 A Systematic Review and Meta-analysis

David Jimenez et al.

Summary: The pooled incidence of VTE and bleeding among hospitalized patients with COVID-19 was 17.0% and 7.8% respectively. Factors such as routine screening, critical illness, inclusion of distal DVT and subsegmental PE, and prospective studies were associated with higher rates of VTE. The incidence of bleeding events was sensitive to escalated doses of anticoagulants and the nature of data collection.

CHEST (2021)

Add to Collection
Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.